Veracyte (FRA:12V) Cyclically Adjusted Book per Share: €8.63 (As of Mar. 2026)


FRA:12V Veracyte Inc FRA:12V
75 GF Score
Price €49.58
GF Value €32.75
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Veracyte Cyclically Adjusted Book per Share?

Veracyte FRA:12V -0.24% 75 Cyclically Adjusted Book per Share is €8.63 as of Mar. 2026. GuruFocus rates FRA:12V with a GF Score™ of 75/100 and a GF Value™ of €32.75 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Veracyte's adjusted book value per share for the three months ended in Mar. 2026 was €14.574. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €8.63 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Veracyte's average Cyclically Adjusted Book Growth Rate was 18.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 22.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Veracyte was 22.30% per year. The lowest was 22.30% per year. And the median was 22.30% per year.

As of today (2026-07-08), Veracyte's current stock price is €49.58. Veracyte's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €8.63. Veracyte's Cyclically Adjusted PB Ratio of today is 5.75.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Veracyte was 7.11. The lowest was 2.56. And the median was 4.04.


Veracyte  (FRA:12V) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Veracyte's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=49.58/8.63
=5.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Veracyte was 7.11. The lowest was 2.56. And the median was 4.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Veracyte Cyclically Adjusted Book per Share Related Terms


Veracyte Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Veracyte's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veracyte Cyclically Adjusted Book per Share Chart

Veracyte Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.07 6.51 8.10 8.50

Veracyte Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.18 7.81 8.08 8.50 8.63

FRA:12V vs RDNT, SHC, BLLN: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Veracyte's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veracyte Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Veracyte's Cyclically Adjusted PB Ratio falls into.


FRA:12V
75GF Score
Veracyte Inc FRA:12V
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veracyte Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Veracyte's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=14.574/330.2130*330.2130
=14.574

Current CPI (Mar. 2026) = 330.2130.

Veracyte Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.078 241.018 1.477
201609 0.957 241.428 1.309
201612 1.673 241.432 2.288
201703 1.473 243.801 1.995
201706 1.256 244.955 1.693
201709 1.057 246.819 1.414
201712 0.919 246.524 1.231
201803 0.709 249.554 0.938
201806 0.641 251.989 0.840
201809 1.679 252.439 2.196
201812 1.716 251.233 2.255
201903 1.786 254.202 2.320
201906 4.113 256.143 5.302
201909 4.297 256.759 5.526
201912 4.343 256.974 5.581
202003 4.171 258.115 5.336
202006 3.981 257.797 5.099
202009 6.208 260.280 7.876
202012 5.949 260.474 7.542
202103 12.171 264.877 15.173
202106 11.947 271.696 14.520
202109 13.248 274.310 15.948
202112 13.644 278.802 16.160
202203 13.794 287.504 15.843
202206 14.068 296.311 15.678
202209 14.756 296.808 16.417
202212 14.105 296.797 15.693
202303 13.952 301.836 15.264
202306 13.757 305.109 14.889
202309 13.531 307.789 14.517
202312 13.068 306.746 14.068
202403 13.466 312.332 14.237
202406 13.709 314.175 14.409
202409 13.674 315.301 14.321
202412 14.440 315.605 15.108
202503 14.115 319.799 14.575
202506 13.469 322.561 13.789
202509 13.558 324.800 13.784
202512 14.093 324.054 14.361
202603 14.574 330.213 14.574

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €8.63 mean?
Veracyte (FRA:12V) has a Cyclically Adjusted Book per Share of €8.63 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Veracyte and its competitors.
Is Veracyte's Cyclically Adjusted Book per Share too high?
Veracyte's current Cyclically Adjusted Book per Share is €8.63. Overall, Veracyte has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Veracyte's Cyclically Adjusted Book per Share compare to RDNT and SHC?
Veracyte's Cyclically Adjusted Book per Share of €8.63 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Veracyte and its competitors. Veracyte's current Cyclically Adjusted Book per Share is €8.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veracyte stock overvalued right now?
Based on GuruFocus' analysis, Veracyte (FRA:12V) is currently considered Significantly Overvalued. The stock's GF Value™ is €32.75, compared to a current price of €49.58 — trading 51.4% above its estimated fair value. The current Cyclically Adjusted Book per Share is €8.63. Veracyte's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Veracyte (FRA:12V), the current Cyclically Adjusted Book per Share is €8.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veracyte (FRA:12V) Overvalued in 2026?

Based on GuruFocus' analysis, Veracyte stock appears to be overvalued. The current stock price of €49.58 is trading 51.4% above its estimated GF Value™ of €32.75. GuruFocus considers Veracyte to be Significantly Overvalued.

Key valuation signals for FRA:12V:

  • Cyclically Adjusted Book per Share: €8.63
  • GF Value™: €32.75 vs. price of €49.58 (51.4% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the FRA:12V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Veracyte Business Description

Other Exchanges VCYT:USA12V:Germany
Address 6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
75GF Score

Get the complete analysis for FRA:12V

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.58
Price
€32.75
GF Value